Tortoise Investment Management’s Immix Biopharma IMMX Stock Holding History

Tortoise Investment Management’s Portfolio IMMX Stock Details IMMX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-1,300	Closed	-$2.86K	–	858
2024 Q4	$2.86K	Hold	1,300	–	–	﹤0.01%	729
2024 Q3	$1.94K	Hold	1,300	–	–	﹤0.01%	767
2024 Q2	$2.57K	Hold	1,300	–	–	﹤0.01%	749
2024 Q1	$3.99K	Hold	1,300	–	–	﹤0.01%	697
2023 Q4	$9K	Hold	1,300	–	–	﹤0.01%	592
2023 Q3	$4.45K	Buy	1,300 +300	+30%	+$703	﹤0.01%	629
2023 Q2	$2.69K	Buy	+1,000	New	+$2.09K	﹤0.01%	667

Other funds holding IMMX

Bleichroeder LP New York $579M AUM 94.36% 1-Year Est. Return

CCC

Cable Car Capital San Francisco, California $289M AUM 26.33% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

PAG

Private Advisor Group Morristown, New Jersey $21.8B AUM 28.57% 1-Year Est. Return

TAM

Tocqueville Asset Management New York $6.74B AUM 32.29% 1-Year Est. Return

Tortoise Investment Management's IMMX Position: Q1 2025 in Review

Tortoise Investment Management sold out of Immix Biopharma (IMMX) in Q1 2025, closing a stake of 1,300 shares — an estimated $2.86K sold.

Tortoise Investment Management first reported a position in IMMX in Q2 2023 and held it in 7 quarters. The position peaked at $9K in Q4 2023. 22 funds tracked by Wall St. Rank hold IMMX as of Q1 2025.

Tortoise Investment Management reported no remaining Immix Biopharma position as of Q1 2025 after selling out during the quarter.
Tortoise Investment Management sold 1,300 Immix Biopharma shares in Q1 2025, an estimated $2.86K.
Tortoise Investment Management first reported a position in Immix Biopharma in Q2 2023 and held it in 7 quarters.
Tortoise Investment Management's Immix Biopharma position peaked at $9K in Q4 2023.
22 funds tracked by Wall St. Rank held Immix Biopharma as of Q1 2025.

Based on Tortoise Investment Management's 13F filing for Q1 2025, filed 14 May 2025.